Possibly no baseline severity effect for antidepressants versus placebo but for antipsychotics. Why?

Stefan Leucht; S. Z. Levine; M. Samara; A. Cipriani; J. M. Davis; T. A. Furukawa

doi:10.1007/s00406-018-0940-0

Possibly no baseline severity effect for antidepressants versus placebo but for antipsychotics. Why?

Stefan Leucht, S. Z. Levine, M. Samara, A. Cipriani, J. M. Davis, T. A. Furukawa

Department of Community Mental Health

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	621-623
Number of pages	3
Journal	European Archives of Psychiatry and Clinical Neuroscience
Volume	268
Issue number	7
DOIs	https://doi.org/10.1007/s00406-018-0940-0
State	Published - 1 Oct 2018

Bibliographical note

Funding Information:
In the last three years Stefan Leucht received honoraria for consulting from LB Pharma, Lundbeck, Otsuka, TEVA, LTS Lohmann, Geodon Richter, Recordati, Boehringer Ingelheim, and Sandoz. For lectures from Janssen, Lilly, Lundbeck, Otsuka, SanofiAventis, Servier and Sunovion. Over 3 years ago, Dr Levine received honoraria and/or research support, and/or consultancy fees and/or travel support from: Shire Pharmaceuticals, F. Hoffmann-La Roche and Eli Lilly. Toshi A Furukawa has received lecture fees from Meiji, Mitsubishi-Tanabe, MSD and Pfizer. He has received research support from Mitsubishi-Tanabe. John M Davis and Myrto Samara have no conflict of interest to declare.

ASJC Scopus subject areas

Psychiatry and Mental health
Biological Psychiatry
Pharmacology (medical)

Access to Document

10.1007/s00406-018-0940-0

Cite this

@article{e5a60203e0674980bd1fc4887cbf741a,

title = "Possibly no baseline severity effect for antidepressants versus placebo but for antipsychotics. Why?",

author = "Stefan Leucht and Levine, {S. Z.} and M. Samara and A. Cipriani and Davis, {J. M.} and Furukawa, {T. A.}",

note = "Funding Information: In the last three years Stefan Leucht received honoraria for consulting from LB Pharma, Lundbeck, Otsuka, TEVA, LTS Lohmann, Geodon Richter, Recordati, Boehringer Ingelheim, and Sandoz. For lectures from Janssen, Lilly, Lundbeck, Otsuka, SanofiAventis, Servier and Sunovion. Over 3 years ago, Dr Levine received honoraria and/or research support, and/or consultancy fees and/or travel support from: Shire Pharmaceuticals, F. Hoffmann-La Roche and Eli Lilly. Toshi A Furukawa has received lecture fees from Meiji, Mitsubishi-Tanabe, MSD and Pfizer. He has received research support from Mitsubishi-Tanabe. John M Davis and Myrto Samara have no conflict of interest to declare.",

year = "2018",

month = oct,

day = "1",

doi = "10.1007/s00406-018-0940-0",

language = "English",

volume = "268",

pages = "621--623",

journal = "European Archives of Psychiatry and Clinical Neuroscience",

issn = "0940-1334",